Brillance attends ASH Annual Meeting 2025 in Orlando
Izabela Kozdraś-Urbanek, Chief Operating & Development Officer at Brillance, attended the ASH Annual Meeting 2025 in Orlando. During the conference, we promoted Poland as an attractive location for conducting clinical trials - combining strong scientific expertise, high Investigator engagement, and efficient study execution.
Brillance provides boutique, highly personalized CRO services, with a particular focus on early-phase clinical trials and dedicated support for biotech companies seeking flexibility, quality, and a true partnership approach.
